Rifaximin treatment for acute recurrent diarrhea in children with genitourinary disorders

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 10, 1998, Pages 746-752

  De Castro, Roberto ^a   Domenichelli, Vincenzo ^a   Di Lorenzo, Francesco Paolo ^a,b   Prestipino, Marco ^a   Perrotta, Maria Luisa ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute recurrent bacterial diarrhea; Nonabsorbable antimicrobials; Pediatrics; Rifaximin

Indexed keywords

COTRIMOXAZOLE; NITROFURANTOIN; RIFAXIMIN;

ARTICLE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FECES CULTURE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; ORAL REHYDRATION THERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 0031789264     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85034-0     Document Type: Article

References (20)

1. Guerrant RL, Hughes JM, Lima NL, Crane J. Diarrhea in developed and developing countries: Magnitude, special settings and etiologies. Rev Infect Dis. 1990;12(Suppl 1):41-50.
2. Fontana M, Zuin G, Paccagnini S, et al. Osservazioni epidemiologiche su 337 casi di diarrea acuta in età infantile. Ann Ist Super Sanit. 1986;22:839-842.
3. Gorbach SL. Bacterial diarrhea and its management. Lancet. 1987;II:1378-1383.
4. DuPont HL, Ericsson CD, Robinson A, Johnson PC. Current problems in antimicrobial therapy for bacterial enteric infection. Am J Med. 1987;82(Suppl 4A):324-328.
5. Hoover WW, Gerlach EH, Hoban DJ, et al. Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative. Diagn Microbiol Infect Dis. 1993;16:111-118.
6. Gillis JC, Brogden RN. Rifaximin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs. 1995;49:467-484.
7. Descombe JJ, Dubourg D, Picard M, Palazzini E. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers. Int J Clin Pharmacol Res. 1994;14:51-56.
8. De Leo C, Eftimiadi C, Schito GC. Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin. Drugs Exp Clin Res. 1986;12:979-981.
9. Alvisi V, D'Ambrosi A, Onofri W, et al. Treatment of secretory diarrheas. A double-blind trial of the effectiveness of rifaximin (L 105) and neomycin. Clin Trials J. 1984;21:215-223.
10. Sanfilippo A, Raciti Longo G, Raciti Longo A. Clinical experience with rifaximin in pediatric diarrheal syndromes. Med Praxis. 1984;5:375-383.
11. Lombardo S, Santangelo G. Therapeutic effectiveness of L105, given in three pediatric formulations, as an intestinal antibacterial agent. Farmaco. 1984;39:170-175.
12. Ambrosioni G, Giovannini G, Lambertini A, et al. Activity and tolerance evaluation in children of a new antidiarrheal drug: Rifaximin. Clin Pediatr. 1984;66:1-10.
13. Luttichau U, Arcangeli P, Sinapi S. The use of rifaximin in the treatment of acute diarrheal enteritis: Open study. Panminerva Med. 1985;27:129-132.
14. Bucci L, Palmieri GC. Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy. Curr Med Res Opin. 1993;13:109-118.
15. Corazza GR, Ventrucci M, Strocchi A, et al. Treatment of small intestine bacterial overgrowth with rifaximin, a non-absorbable rifamycin. J Int Med Res. 1988;16:312-316.
16. Papi C, Ciaco A, Koch M. Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Ital J Gastroenterol. 1992;24:452-456.
17. Gruttadauria G, La Barbera F, Cutaia G, Salanitri G. Prevention of infection in colonic surgery by rifaximin. A controlled, prospective, randomized trial. Eur Rev Med Pharmacol Sci. 1987;9:101-105.
18. Verardi S, Verardi V, Fusillo M. Rifaximin effectiveness evaluation in the preparation of large intestine to surgery. Eur Rev Med Pharmacol Sci. 1986;8:267-270.
19. World Health Organization. A Manual for the Treatment of Acute Diarrhea. Geneva: WHO/CDD/SER/60.2; 1980.
20. DuPont HL, Cooperstock M, Corrado ML, et al. General guidelines for the evaluation of new anti-infective drugs for the treatment of gastrointestinal infections. Clin Infect Dis. 1992;15(Suppl 1):S228-S235.